MGF (Mechano Growth Factor)

Overview

MGF (mechano growth factor) is a splice variant of the IGF-1 gene — known as IGF-1Ec in humans — that muscle produces locally in response to mechanical loading and damage, and it is hypothesized to activate satellite (muscle stem) cells to support repair and growth. Synthetic 'MGF' and 'PEG-MGF' products on the market correspond to its unique E-peptide region. It is not FDA-approved for any indication, and the evidence base is overwhelmingly preclinical: cell-culture and animal studies on satellite-cell activation, with no adequate controlled human trials demonstrating that injected MGF builds muscle in people. Marketed claims about hypertrophy and recovery should be treated as unproven.

Commonly Reported Uses

These are uses commonly discussed or marketed by users and vendors — not a list of proven or approved benefits, and not a recommendation.

• Muscle repair and satellite-cell activation (preclinical concept; human evidence lacking)
• Muscle growth / hypertrophy (marketed claim; human evidence lacking)
• Post-exercise recovery (marketed claim; human evidence lacking)
• Tissue repair and 'regeneration' (marketed claim; not an approved use)

What to Track

Data points you and your clinician might monitor. For observation only — not a diagnostic protocol.

• InBody/DEXA — skeletal muscle mass and body-fat % over a defined baseline
• WHOOP — recovery score and HRV trend across a training block
• Subjective daily check-ins — training performance, soreness, recovery
• Smart scale — weight and body-fat % trend
• Labs — a clinician-monitored panel if growth-factor exposure is being watched

Sources & References

1. [1]Insulin-Like Growth Factor I (IGF-1) Ec/Mechano Growth Factor — A Splice Variant of IGF-1 within the Growth Plate — PMC
2. [2]List of drugs banned by the World Anti-Doping Agency — Wikipedia